Alnylam Pharma (ALNY) Tops Q2 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Alnylam Pharmaceuticals (ALNY) PT Raised to $210 at B.Riley/FBR
August 3, 2018 9:17 AM EDTB.Riley/FBR raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $210.00 (from $200.00) while maintaining a Buy rating.
... MoreAlnylam Pharmaceuticals (ALNY) PT Lowered to $99 at Morgan Stanley
August 3, 2018 7:42 AM EDTMorgan Stanley lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $99.00 (from $107.00) while maintaining a Equalweight rating.
... More